3M CO MMM
Surgical & Medical Instruments & Apparatus ยท NYSE
์์ต
$24.61B
-5.9% ๋
๋๋
๋
์์์ต
$-7.00B
-221.1% ๋
๋๋
๋
์ด ์์ฐ
$39.87B
-21.2% ๋
๋๋
๋
EPS
-12.63
-224.1% ๋
๋๋
๋
Advertisement
Income Statement
| ๊ธฐ๊ฐ | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 FY | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 FY |
|---|---|---|---|---|---|---|---|---|
| Revenues | $18.82B | $12.30B | $5.95B | $24.61B | $18.57B | $12.27B | $6.02B | $26.16B |
| Cost of Revenue | $10.92B | $7.12B | $3.48B | $14.98B | $10.70B | $7.06B | $3.48B | $15.85B |
| R&D Expense | โ | โ | โ | โ | โ | โ | โ | $800.00M |
| SG&A Expense | $3.03B | $2.21B | $945.00M | $19.20B | $3.32B | $2.26B | $1.13B | $7.23B |
| Operating Income (Loss) | $3.83B | $2.39B | $1.25B | $-10.69B | $3.74B | $2.42B | $1.15B | $4.37B |
| Interest Expense | โ | โ | โ | โ | โ | โ | โ | โ |
| Net Income (Loss) | $2.67B | $1.84B | $1.12B | $-7.00B | $3.44B | $2.07B | $928.00M | $5.78B |
| EPS (Diluted) | 4.93 | 3.38 | 2.04 | -12.63 | 6.21 | 3.73 | 1.67 | 10.18 |
์ฌ๋ฌดํ
| ๊ธฐ๊ฐ | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 FY | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 FY |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $37.73B | $37.73B | $37.73B | $39.87B | $39.87B | $39.87B | $39.87B | $50.58B |
| Current Assets | $16.39B | $16.39B | $16.39B | $15.88B | $15.88B | $15.88B | $15.88B | $16.38B |
| Cash & Equivalents | โ | โ | โ | โ | โ | โ | โ | โ |
| Accounts Receivable | $3.53B | $3.53B | $3.53B | $3.19B | $3.19B | $3.19B | $3.19B | $3.60B |
| Inventory | $3.66B | $3.66B | $3.66B | $3.70B | $3.70B | $3.70B | $3.70B | $3.94B |
| PP&E (Net) | $7.10B | $7.10B | $7.10B | $7.39B | $7.39B | $7.39B | $7.39B | $7.69B |
| Goodwill | $6.28B | $6.42B | $6.42B | $6.38B | $6.28B | $6.28B | $6.28B | $6.34B |
| Total Liabilities | $32.99B | $32.99B | $32.99B | $35.97B | $35.97B | $35.97B | $35.97B | $45.71B |
| Current Liabilities | $9.60B | $9.60B | $9.60B | $11.26B | $11.26B | $11.26B | $11.26B | $15.30B |
| Accounts Payable | $2.70B | $2.70B | $2.70B | $2.66B | $2.66B | $2.66B | $2.66B | $2.78B |
| Long-Term Debt | $14.99B | โ | โ | $13.04B | $12.60B | $13.15B | $13.48B | $14.24B |
| Stockholders Equity | $4.70B | $4.70B | $4.70B | $3.84B | $3.84B | $3.84B | $3.84B | $4.81B |
Cash Flow Statement
| ๊ธฐ๊ฐ | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 FY | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 FY |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $723.00M | $-1.03B | $-79.00M | $6.68B | $1.00M | $1.79B | $767.00M | $5.59B |
| Investing Cash Flow | $1.75B | $1.29B | $1.22B | $-1.21B | $-2.06B | $-856.00M | $-393.00M | $-1.05B |
| Financing Cash Flow | $-3.40B | $-2.19B | $-422.00M | $-3.15B | $2.18B | $3.26B | $4.62B | $-5.35B |
| Stock Repurchases | $2.70B | $2.23B | $1.27B | $33.00M | $1.10B | $421.00M | $21.00M | $1.46B |
์ ์ฌ ๊ธฐ์
BAXTER INTERNATIONAL INC
BAX
BECTON DICKINSON & CO
BDX
BOSTON SCIENTIFIC CORP
BSX
DEXCOM INC
DXCM
INSULET CORP
PODD
RESMED INC
RMD
Solventum Corp
SOLV
STRYKER CORP
SYK
๋ ์์๋ณด๊ธฐ
How to Find Any SEC Filing in Two MinutesCash-Flow Quality: Profit Is an Opinion, Cash Is a FactValuation Basics: P/E, P/S and What They Actually Tell YouDividends: How Companies Pay Shareholders and How to Read ThemHow to Read a 10-K Annual Report (Without Falling Asleep)Understanding Earnings Per Share (EPS)How to Read a Cash Flow StatementHow to Read a Balance SheetHow to Read an Income Statement
๋ฐ์ดํฐ๋ ๋ฏธ๊ตญ SEC EDGAR ๊ณต๊ณต ๋ฐ์ดํฐ๋ฒ ์ด์ค์์ ์์ง๋์์ต๋๋ค. ์ด ์ฌ์ดํธ๋ ํฌ์ ์กฐ์ธ์ ์ ๊ณตํ์ง ์์ต๋๋ค.